LIPIDOMIC ANALYSIS OF ACUTE MYELOID LEUKAEMIA CELL RESPONSES TO BEZAFIBRATE AND MEDROXYPROGESTERONE ACETATE REVEALS INSIGHTS INTO THEIR ANTI-LEUKEMIC ACTION

被引:0
|
作者
Southam, Andrew [1 ]
Khanim, Farhat [1 ]
Hayden, Rachel [1 ]
Michell, Robert [1 ]
Lilly, Andrew [1 ]
Gunther, Ulrich [1 ]
Drayson, Mark [1 ]
Viant, Mark [1 ]
Bunce, Chris [1 ]
机构
[1] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S149 / S149
页数:1
相关论文
共 23 条
  • [1] MASS SPECTROMETRY METABOLOMICS ANALYSIS OF ACUTE MYELOID LEUKAEMIA CELL RESPONSES TO BEZAFIBRATE AND MEDROXYPROGESTERONE ACETATE
    Southam, A. D.
    Khanim, F.
    Hayden, R. E.
    Gunther, U. L.
    Drayson, M. T.
    Viant, M. R.
    Bunce, C. M.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S89 - S90
  • [2] Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
    Khanim, Farhat L.
    Hayden, Rachel E.
    Birtwistle, Jane
    Lodi, Alessia
    Tiziani, Stefano
    Davies, Nicholas J.
    Ride, Jon P.
    Viant, Mark R.
    Gunther, Ulrich L.
    Mountford, Joanne C.
    Schrewe, Heinrich
    Green, Richard M.
    Murray, Jim A.
    Drayson, Mark T.
    Bunce, Chris M.
    PLOS ONE, 2009, 4 (12):
  • [3] Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)
    Murray, Jim A.
    Khanim, Farhat L.
    Hayden, Rachel E.
    Craddock, Charlie F.
    Holyoake, Tessa L.
    Jackson, Nick
    Lumley, Matthew
    Bunce, Chris M.
    Drayson, Mark T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (01) : 65 - 69
  • [4] Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action
    Lainey, Elodie
    Thepot, Sylvain
    Bouteloup, Cyrielle
    Sebert, Marie
    Ades, Lionel
    Tailler, Maximilien
    Gardin, Claude
    de Batton, Stephane
    Baruchel, Andre
    Fenaux, Pierre
    Kraemer, Guido
    Boehrer, Simone
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1457 - 1466
  • [5] ACUTE MYELOID-LEUKEMIA OF THE BN RAT - MODEL FOR CELL-KINETICS SCHEDULING OF ANTI-LEUKEMIC DRUGS
    AGLIETTA, M
    SONNEVELD, P
    EXPERIMENTAL HEMATOLOGY, 1979, 7 : 137 - 137
  • [6] Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines
    Tomaz, Victoria
    Griesi-Oliveira, Karina
    Puga, Renato D.
    de Souza Santos, Fabio Pires
    Hamerschlak, Nelson
    Campregher, Paulo Vidal
    BLOOD, 2021, 138
  • [7] The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia
    van der Hoorn, MAWG
    van Luxemburg-Heijs, SAP
    van Bergen, CAM
    Bongaerts, R
    Willemze, R
    Falkenburg, JHF
    METHODS, 2003, 31 (02) : 113 - 119
  • [8] Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
    Michallet, Mauricette
    Sobh, Mohamad
    Labussiere, Helene
    Lombard, Christine
    Barraco, Fiorenza
    El-Hamri, Mohamed
    Thomas, Xavier
    Chapuis-Cellier, Colette
    Nicolini, Franck E.
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 237 - 240
  • [9] PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
    Diede van Ens
    Charlotte M. Mousset
    Tim J. A. Hutten
    Anniek B. van der Waart
    Diana Campillo-Davo
    Sanne van der Heijden
    Denise Vodegel
    Hanny Fredrix
    Rob Woestenenk
    Loreto Parga-Vidal
    Joop H. Jansen
    Nicolaas P. M. Schaap
    Eva Lion
    Harry Dolstra
    Willemijn Hobo
    Bone Marrow Transplantation, 2020, 55 : 2308 - 2318
  • [10] A new vitamin D3 analog, HY-11, influences acute myeloid leukemia cell on anti-leukemic effects
    Yoon, JS
    Yim, JY
    Park, HK
    Kim, ES
    Cho, CG
    Kim, BK
    Lee, Y
    BLOOD, 2003, 102 (11) : 249B - 249B